VIRGINIA RETIREMENT SYSTEMS ET Al Acquires 17,400 Shares of Maximus, Inc. $MMS

VIRGINIA RETIREMENT SYSTEMS ET Al boosted its position in shares of Maximus, Inc. (NYSE:MMS) by 404.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 21,700 shares of the health services provider’s stock after purchasing an additional 17,400 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in Maximus were worth $1,873,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. increased its stake in shares of Maximus by 19.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 200,331 shares of the health services provider’s stock valued at $18,304,000 after acquiring an additional 33,136 shares during the last quarter. Divisadero Street Capital Management LP increased its stake in shares of Maximus by 93.5% in the 3rd quarter. Divisadero Street Capital Management LP now owns 183,872 shares of the health services provider’s stock valued at $16,800,000 after acquiring an additional 88,872 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Maximus by 2.0% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider’s stock valued at $170,812,000 after purchasing an additional 36,989 shares during the period. Stephens Investment Management Group LLC grew its position in shares of Maximus by 49.0% in the 3rd quarter. Stephens Investment Management Group LLC now owns 720,943 shares of the health services provider’s stock valued at $65,873,000 after purchasing an additional 237,097 shares during the period. Finally, WINTON GROUP Ltd acquired a new position in shares of Maximus in the 3rd quarter valued at approximately $6,208,000. 97.21% of the stock is owned by institutional investors.

Maximus Trading Down 1.3%

NYSE MMS opened at $59.16 on Friday. Maximus, Inc. has a 12 month low of $57.32 and a 12 month high of $100.00. The stock has a 50 day moving average of $67.07 and a 200-day moving average of $78.95. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.87. The company has a market cap of $3.11 billion, a PE ratio of 8.86 and a beta of 0.60.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.98 by $0.09. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The business had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.32 billion. During the same quarter in the prior year, the business earned $2.01 EPS. The firm’s revenue for the quarter was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. On average, equities research analysts anticipate that Maximus, Inc. will post 8.4 EPS for the current fiscal year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Friday, May 15th will be paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date is Friday, May 15th. Maximus’s dividend payout ratio is 19.76%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Zacks Research lowered Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Wall Street Zen downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. Finally, Weiss Ratings downgraded Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, February 24th. Two investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company has an average rating of “Hold”.

Insiders Place Their Bets

In related news, Director Jan Madsen sold 742 shares of the stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the sale, the director owned 20,795 shares in the company, valued at approximately $1,502,438.75. This represents a 3.45% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.80% of the company’s stock.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.